Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 16226 - 16250 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Carvedilol	Approved Investigational	HMOX1	3162	upregulated	carvedilol results in increased expression of HMOX1 mRNA	22q12.3	A21559 A21560
Carvedilol	Approved Investigational	TGFB1	7040	downregulated	carvedilol results in decreased expression of TGFB1 mRNA	19q13.1	A21559 A21560
Custirsen	Investigational	ACAP2	23527	upregulated	CC-8490 results in increased expression of ACAP2 mRNA	3q29	A3616
Custirsen	Investigational	ACTR1B	10120	downregulated	CC-8490 results in decreased expression of ACTR1B mRNA	2q11.2	A3616
Custirsen	Investigational	ATF3	467	upregulated	CC-8490 results in increased expression of ATF3 mRNA	1q32.3	A3616
Custirsen	Investigational	BCL6	604	upregulated	CC-8490 results in increased expression of BCL6 mRNA	3q27.3	A3616
Custirsen	Investigational	CDK1	983	downregulated	CC-8490 results in decreased expression of CDK1 mRNA	10q21.2	A3616
Custirsen	Investigational	CEBPB	1051	upregulated	CC-8490 results in increased expression of CEBPB mRNA	20q13.13	A3616
Custirsen	Investigational	CTBS	1486	upregulated	CC-8490 results in increased expression of CTBS mRNA	1p22.3	A3616
Custirsen	Investigational	CXCL8	3576	upregulated	CC-8490 results in increased expression of CXCL8 mRNA	4q13.3	A3616
Custirsen	Investigational	DAG1	1605	upregulated	CC-8490 results in increased expression of DAG1 mRNA	3p21.31	A3616
Custirsen	Investigational	DDIT3	1649	upregulated	CC-8490 results in increased expression of DDIT3 mRNA	12q13.3	A3616
Custirsen	Investigational	DDX42	11325	upregulated	CC-8490 results in increased expression of DDX42 mRNA	17q23.3	A3616
Custirsen	Investigational	DUSP5	1847	upregulated	CC-8490 results in increased expression of DUSP5 mRNA	10q25.2	A3616
Custirsen	Investigational	EIF5	1983	upregulated	CC-8490 results in increased expression of EIF5 mRNA	14q32.32	A3616
Custirsen	Investigational	GADD45A	1647	upregulated	CC-8490 results in increased expression of GADD45A mRNA	1p31.3	A3616
Custirsen	Investigational	GFPT1	2673	upregulated	CC-8490 results in increased expression of GFPT1 mRNA	2p13.3	A3616
Custirsen	Investigational	IER3	8870	upregulated	CC-8490 results in increased expression of IER3 mRNA	6p21.33	A3616
Custirsen	Investigational	IL6	3569	upregulated	CC-8490 results in increased expression of IL6 mRNA	7p15.3	A3616
Custirsen	Investigational	KYNU	8942	upregulated	CC-8490 results in increased expression of KYNU mRNA	2q22.2	A3616
Custirsen	Investigational	LARP6	55323	upregulated	CC-8490 results in increased expression of LARP6 mRNA	15q23	A3616
Custirsen	Investigational	MCM7	4176	downregulated	CC-8490 results in decreased expression of MCM7 mRNA	7q22.1	A3616
Custirsen	Investigational	NFKB1	4790	upregulated	CC-8490 results in increased expression of NFKB1 mRNA	4q24	A3616
Custirsen	Investigational	PCLAF	9768	downregulated	CC-8490 results in decreased expression of PCLAF mRNA	15q22.31	A3616
Custirsen	Investigational	PGGT1B	5229	upregulated	CC-8490 results in increased expression of PGGT1B mRNA	5q22.3	A3616

Displaying entries 16226 - 16250 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability